Prospective observational studies in clinical research: pros and cons
Abstract
Prospective observational studies are essential in clinical research, mainly when randomized controlled trials (RCTs) are infeasible, unethical, or impractical. These studies involve the prospective collection of data from cohorts stratified by exposure status, allowing investigators to observe the natural progression of outcomes while preserving temporality. Their main strengths include measuring incidence, assessing multiple outcomes, and avoiding recall bias, thus offering valuable insights into real-world clinical practices. However, these studies also face inherent limitations, most notably the risk of confounding, the absence of randomization, extended duration, and high resource demands. Biases related to selection, performance, and attrition can compromise internal validity if not adequately addressed through rigorous design and statistical adjustment. Although generally favorable, ethical considerations must be carefully navigated, especially concerning data protection and informed consent. While causality cannot be established, prospective observational studies complement RCTs by reflecting effectiveness in typical clinical settings. This Pros & Cons review examines the structure, advantages, limitations, and methodological considerations of prospective observational studies, incorporating insights from contemporary medical literature and educational frameworks. It also underscores their continued relevance in evidence-based medicine.
References
- Bonaventura A, Buso R, Dentali F. The research question: a first, essential step in study design. Ital J Med 2026;20:2130. DOI: https://doi.org/10.4081/itjm.2026.2130
- Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92. DOI: https://doi.org/10.1056/NEJM200006223422507
- Hernan MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 2016;183:758-64. DOI: https://doi.org/10.1093/aje/kwv254
- Thiese MS. Observational and interventional study design types; an overview. Biochem Med 2014;24:199-210. DOI: https://doi.org/10.11613/BM.2014.022
- Hess DR. Observational studies. Respir Care 2023;68:1585-97. DOI: https://doi.org/10.4187/respcare.11170
- Van Kha V, Thi Huong Ly T, Thi Thanh Hoa P, Huynh Nhu V. Employing the European Thyroid Imaging Reporting and Data System 2017 classification in a malignancy risk stratification system for thyroid nodules at Can Tho Oncology Hospital from 2021 to 2023. Ital J Med 2025;19:1852. DOI: https://doi.org/10.4081/itjm.2025.1852
- Kannel WB, Dawber TR, Kagan A, et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med 1961;55:33-50. DOI: https://doi.org/10.7326/0003-4819-55-1-33
- Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. DOI: https://doi.org/10.1079/PHN2002394
- Maino A, Bertù L, Squizzato A, et al. Quantifying treatment effect: relative and absolute measures in clinical research. Ital J Med 2026;20:2386. DOI: https://doi.org/10.4081/itjm.2026.2386
- Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007;147:W163-94. DOI: https://doi.org/10.7326/0003-4819-147-8-200710160-00010-w1
- von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-8. DOI: https://doi.org/10.1136/bmj.39335.541782.AD
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.